Ebola Therapeutic Study and Future Directions

doi:10.2174/1871526518666180813160348

	Ebola Therapeutic Study and Future Directions
	Lu, Da-Yong 3; Wu, Hong-Ying 1; Yarla, Nagendra Sastry 2; Lu, Ting-Ren 1; Xu, Bin4
刊名	Infectious disorders drug targets
	2018-08-13
ISSN号	2212-3989
DOI	10.2174/1871526518666180813160348
文献子类	Article
英文摘要	The constant Ebola epidemic outbreaks in Africa arisen waves of panic worldwide. There is a high mortality rate (30-70%) among Ebola infected people in virus-stricken areas. Despite these horrors, the medical capabilities against this deadly viral disease were provided by limited therapeutic agents/options. As a result, several patented agents, biotherapies or prophylactic/therapeutic vaccines need to be reviving into the global markets-including patents of small molecular chemicals, short sequences or oligomers of DNA/RNA, linkages of chemicals with bio-molecules, herbal medicine and so on. In addition, the possible mechanisms of action of these therapeutic options are underway. To promote Ebola biomedical study, the multiple characters of Ebola infections-its origin, pathologic progresses, genomic changes, therapeutic context and economic considerations are outlined in this review. Finally a great difference can be expected after these types of efforts.
语种	英语
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/266303]
专题	院士及顾问专家
作者单位	1.College of Science, Shanghai University, Shanghai, Shanghai200444. China; 2.GITAM University, Viskhatnam, AP. India; 3.School of Life Sciences, Shanghai University, Shanghai, Shanghai200444. China; 4.Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, Shanghai201203. China
推荐引用方式 GB/T 7714	Lu, Da-Yong,Wu, Hong-Ying,Yarla, Nagendra Sastry,et al. Ebola Therapeutic Study and Future Directions[J]. Infectious disorders drug targets,2018.
APA	Lu, Da-Yong,Wu, Hong-Ying,Yarla, Nagendra Sastry,Lu, Ting-Ren,&Xu, Bin.(2018).Ebola Therapeutic Study and Future Directions.Infectious disorders drug targets.
MLA	Lu, Da-Yong,et al."Ebola Therapeutic Study and Future Directions".Infectious disorders drug targets (2018).